Apollo Hospitals plans 4,198 beds to reach 13,800 by FY31

Apollo Hospitals Enterprise Ltd plans to add 4,198 census beds through FY31, lifting current census capacity from 9,605 beds in Q2FY27 to about 13,800, after 520 of 4,718 census beds in its expansion pipeline had been operationalised. The programme covers 5,798 total beds and has about Rs 7,100 crore of spending remaining.

How many beds is Apollo Hospitals adding through FY31?

Apollo Hospitals is planning to add 4,198 census beds that were still to be operationalised from its 4,718-bed expansion pipeline in Q2FY27. The presentation calculates the balance after deducting 520 operationalised census beds from the 4,718 census beds under expansion. It places current census capacity at 9,605 beds and post-expansion capacity at about 13,800 beds.

The 4,198-bed expansion balance differs from the Healthcare Services operating-bed count of 8,522 in the second quarter of fiscal year 2027, or Q2FY27. Healthcare Services had 48 hospitals and 8,522 operating beds in Q2FY27, compared with 45 hospitals and 8,050 beds in Q2FY26. The expansion presentation uses a broader current census-bed measure of 9,605 beds.

Apollo Hospitals lists 5,798 total project beds and 4,718 census beds across three fiscal-year periods. Census beds are lower than total beds in every phase, including 1,395 census beds against 1,720 total beds in FY26-FY27 and 2,996 against 3,678 in FY30-FY31.

Where will Apollo Hospitals add the most capacity?

Apollo Hospitals has its largest planned projects in FY30-FY31, when it lists 2,996 census beds and Rs 7,393 crore of project cost. OMR in Chennai and Worli in Mumbai are each planned for 500 census beds, while Dwarka in Delhi is planned for 480 census beds. Together, those three projects account for 1,480 census beds.

The rest of the FY30-FY31 programme includes Sarjapur-2 with 360 census beds, Varanasi with 300, Ranchi with 240 and Indore with 164. Lucknow's brownfield expansion is listed at 160 census beds, Hyderabad's comprehensive cancer care and proton project at 110, Delhi Cancer Centre and Proton at 100, and Guwahati at 82.

In Chennai, Apollo Hospitals plans a 600-total-bed greenfield hospital at OMR with 500 census beds. Its Tamil Nadu regional presentation shows Chennai increasing from 1,340 current beds to 1,840 post expansion, while the wider Tamil Nadu region rises from 2,005 beds to 2,505. The 500-bed increase matches the OMR census-bed plan.

Hyderabad's disclosed pipeline combines one asset-light greenfield project with brownfield additions. Gachibowli has 300 census beds, Jubilee Hills and Secunderabad have 80 each, and the comprehensive cancer care and proton project has 110, taking the total to 570 census beds. The regional presentation shows Hyderabad moving from 944 current beds to 1,359 post expansion.

What capacity has Apollo Hospitals already operationalised?

Apollo Hospitals says 520 census beds had been operationalised from the approximately 1,000 census beds in five new hospitals, excluding Gurgaon. The remaining 480 census beds are planned to be progressively activated over the next 12 to 18 months under the company's phased ramp-up plan.

The FY26-FY27 list includes Pune, Sonarpur in Kolkata, Gachibowli in Hyderabad, Defence Colony in Delhi, Sarjapur-1 and Gurgaon. These six listed projects total 1,720 beds and 1,395 census beds, at a stated project cost of Rs 3,185 crore. Gurgaon accounts for 469 total beds and 380 census beds, but the presentation does not state an operationalised-bed number for it.

Gachibowli accounted for 155 of the 520 operationalised census beds, followed by Pune with 125, Sonarpur with 100, Sarjapur-1 with 100 and Defence Colony with 40. The FY28-FY29 stage is smaller, with 327 census beds and Rs 575 crore of project cost across Jubilee Hills, Secunderabad, Malleswaram and Mysore, and Indore Oncology.

What operating data accompany Apollo Hospitals' expansion plan?

Apollo Hospitals reported 73% occupancy in Q2FY27, up from 69% in Q2FY26, while operating beds rose 5.9% to 8,522. Inpatient volume increased 14.1% to 185,980, average revenue per inpatient rose 7.9% to Rs 186,880, and average length of stay declined to 3.07 days from 3.14 days.

The metropolitan network operated 4,966 beds at 74% occupancy in Q2FY27, compared with 3,556 beds at 70% occupancy in non-metros. Average revenue per inpatient was Rs 222,626 in metros and Rs 133,654 in non-metros. The presentation states that both geographic sets of figures include new hospitals.

Healthcare Services revenue was Rs 3,899.8 crore in Q2FY27, up 23% from Rs 3,169 crore in Q2FY26. Earnings before interest, tax, depreciation and amortisation, or EBITDA, after Ind AS 116, rose 20% to Rs 936.5 crore, while its margin moved to 24.0% from 24.6% a year earlier.

The presentation attributes the 23% revenue increase to 14% overall volume growth, including 10% established-unit volume growth, alongside 4% price and 5% case-mix or payor-mix effects. New-unit pre-operative expenses or losses were Rs 34.8 crore in Q2FY27, while established units reported a 25.8% EBITDA margin. Oncology revenue grew 28%, gastroenterology 27%, urology 26%, and cardiac and orthopaedics 20%.

Conclusion

Apollo Hospitals' disclosed programme would add 4,198 remaining census beds to a current census capacity of 9,605, taking the network to about 13,800 beds. The largest part of the programme is scheduled for FY30-FY31, with 2,996 census beds and Rs 7,393 crore of listed project cost, led by Chennai, Mumbai and Delhi developments.

The next disclosed milestone is the progressive activation of 480 census beds over the next 12 to 18 months from the approximately 1,000-bed commissioned cohort. Apollo Hospitals also says it will continue to evaluate bolt-on acquisitions in select Tier-1 cities and metros, while about Rs 7,100 crore remains to be spent on the stated pipeline.